BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 7608539)

  • 1. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1993 Jul; 151(2):668-77. PubMed ID: 8335902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
    Gaus H; Miethke T; Wagner H; Heeg K
    Immunology; 1994 Nov; 83(3):333-40. PubMed ID: 7835956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.
    Florquin S; Amraoui Z; Goldman M
    Eur J Immunol; 1995 May; 25(5):1148-53. PubMed ID: 7774618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B.
    Nagelkerken L; Gollob KJ; Tielemans M; Coffman RL
    Eur J Immunol; 1993 Sep; 23(9):2306-10. PubMed ID: 8370407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM; Alard P; Liang S; Clark SL
    Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
    Yotsukura J; Huang H; Singh AK; Shichi H
    Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo.
    Nakata Y; Matsuda K; Uzawa A; Nomura M; Akashi M; Suzuki G
    J Immunol; 1995 Nov; 155(9):4231-5. PubMed ID: 7594579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F; Garcia-Sanz JA; Moriggl R; Wild MT
    J Immunol; 1999 Jan; 162(1):209-14. PubMed ID: 9886388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines.
    Baschieri S; Lees RK; Lussow AR; MacDonald HR
    Eur J Immunol; 1993 Oct; 23(10):2661-6. PubMed ID: 8104798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine deviation induced by intrathymic injection of staphylococcal enterotoxin B (SEB).
    Goettelfinger P; Lecerf F; Berrih-Aknin S; German-Fattal M
    Eur Cytokine Netw; 2001; 12(3):487-500. PubMed ID: 11566630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal enterotoxin B induces the expression of activation markers on murine memory T cells in the absence of proliferation or lymphokine secretion.
    Lee WT; Thrush GR; Vitetta ES
    Cell Immunol; 1995 Apr; 162(1):26-32. PubMed ID: 7704907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.